A. Frazier

发表

N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease

A. Hannan, L. Gray, Ann E. Frazier, 2015, Translational Psychiatry.

Abstract GS4-10: Neratinib + fulvestrant + trastuzumab for hormone receptor-positive, HER2-mutant metastatic breast cancer and neratinib + trastuzumab for triple-negative disease: Latest updates from the SUMMIT trial

H. Wildiers, A. Guerrero-Zotano, E. Yang, 2022, Cancer Research.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

S. Loi, M. Burkard, R. Bose, 2023, Annals of Oncology.

M. Burkard, D. Solit, H. Wildiers, 2022 .